This site is intended for U.S. healthcare professionals.

YCANTH™, the FDA-approved in-office treatment for molluscum contagiosum in patients 2+, is available.
Fill out our survey to see if you qualify to become a YCANTH prescriber.

FAQ

How can prescribers know they are administering YCANTH properly?

Verrica offers in-office training to give your practice the best experience with the YCANTH applicator. Call 1-877-VERRICA to request in-office training.

Please see full Prescribing Information for dosing and administration information included the complete Instructions for use.

Who should become a prescriber?

You should answer a few easy questions to become a certified prescriber if:

  • You are a licensed pediatrician who sees molluscum patients whether routinely or sporadically
  • You are a healthcare professional who treats skin disorders like molluscum contagiosum
  • You are interested in learning more about in-office therapy
  • You are willing to participate in a brief training program

What Are The Benefits of Treating?

Treating molluscum can limit spread and may have additional benefits1,2,3

  • Reduces disease progression and transmission, including autoinoculation.
  • Prevents exacerbations of comorbidities, such as atopic dermatitis, and may help prevent bacterial infections.
  • Reduces discomfort and itching.
  • May reduce the negative impacts on quality of life due to scarring, bullying, and exclusion from activities.
  • May help alleviate anxiety in caregivers
1: Kwong, P., Hebert, A., Utley, C., & Olivadoti, M. (2021). The Hidden Impact of Molluscum Contagiosum: A Survey of Caregivers’ Experiences with Diagnosis, Treatment, and Impact on Quality of Life. SKIN The Journal of Cutaneous Medicine, 5(4), 363–371. https://doi.org/10.25251/skin.5.4.5
2: IQVIA Market Sizing Study. July 2018.
3: https://www.ycanthpro.com/efficacy

Are there any costs to become a prescriber?

No, qualified prescribers do not pay for the training program.

Are there any side effects?

The most common adverse reactions to YCANTH occurred at the application site, and included blistering, pain, itching, scabbing, reddening, discoloration, dryness, edema (swelling), and erosion of the skin. Contact with the treatment area should be avoided, including oral contact, after treatment. YCANTH is flammable, even after drying.

See full Prescribing Information for additional information on risks associated with YCANTH.

What are the symptoms of molluscum contagiosum?

Signs may include:4,5

  • Raised, round, flesh-colored bumps
  • Small bumps on skin that are typically ¼ inch in diameter total
  • The appearance of a small dent or dot at the top of the bumps, near the center
  • Itchy, pink bumps on the face, arms, legs or trunk of small children
  • Bumps on the genital area, inner thighs or lower abdomen on adults if the infection was sexually transmitted

 

4: Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019;12:373-381. doi:10.2147/CCID.S187224
5: Damon IK. Smallpox, monkeypox, and other poxvirus infections. In: Goldman L, Schafer AI, eds. Goldman’s Cecil Medicine. 25th ed. Elsevier Saunders; 2016:2214-2219.

What if I have more questions?

If you are interested in learning more, you may email us at [email protected]
Learn more about how to become a YCANTH prescriber and help get patients the relief they need.
.